Mild acquired factor XIII deficiency and clinical relevance at the ICU

• Verfasst von: Schmitt, Felix [VerfasserIn]
• Verfasst von: Forst, Maik von der [VerfasserIn]
• Verfasst von: Miesbach, Wolfgang [VerfasserIn]
• Verfasst von: Casu, Sebastian [VerfasserIn]
• Verfasst von: Weigand, Markus A. [VerfasserIn]
• Verfasst von: Alesci, Sonja [VerfasserIn]
• Titel: Mild acquired factor XIII deficiency and clinical relevance at the ICU
• Titelzusatz: a retrospective analysis
• Verf.angabe: Felix Carl Fabian Schmitt, Maik von der Forst, Wolfgang Miesbach, Sebastian Casu, Markus Alexander Weigand, and Sonja Alesci
• E-Jahr: 2021
• Jahr: 24 May 2021
• Umfang: 7 S.
• Teil: volume:27
• Teil: year:2021
• Teil: elocationid:10760296211024741
• Teil: pages:1-7
• Teil: extent:7
• Fussnoten: Gesehen am 15.10.2021
• Titel Quelle: Enthalten in: Clinical and applied thrombosis, hemostasis
• Ort Quelle: Thousand Oaks, Calif. : Sage, 1995
• Jahr Quelle: 2021
• Band/Heft Quelle: 27(2021), Artikel-ID 10760296211024741, Seite 1-7
• ISSN Quelle: 1938-2723
• DOI: doi:10.1177/10760296211024741
• Datenträger: Online-Ressource
• Sprache: eng
• Sach-SW: blood coagulation
• Sach-SW: blood transfusion
• Sach-SW: critical care
• Sach-SW: factor XIII
• Sach-SW: hemorrhage
• K10plus-PPN: 1774164221

Abstract

Acquired FXIII deficiency is a relevant complication in the perioperative setting; however, we still have little evidence about the incidence and management of this rarely isolated coagulopathy. This study aims to help find the right value for the substitution of patients with an acquired mild FXIII deficiency. In this retrospective single-center cohort study, we enrolled critically ill patients with mild acquired FXIII deficiency (>5% and ≤70%) and compared clinical and laboratory parameters, as well as pro-coagulatory treatments. The results of the present analysis of 104 patients support the clinical relevance of FXIII activity out of the normal range. Patients with lower FXIII levels, beginning at <60%, had lower minimum and maximum hemoglobin values, corresponding to the finding that patients with a minimum FXIII activity of <50% needed significantly more packed red blood cells. FXIII activity correlated significantly with general coagulation markers such as prothrombin time, activated partial thromboplastin time, and fibrinogen. Nevertheless, comparing the groups with a cut-off of 50%, the amount of fresh frozen plasma, thrombocytes, PPSB, AT-III, and fibrinogen given did not differ. These results indicate that a mild FXIII deficiency occurring at any point of intensive care unit stay is also probably relevant for the total need of packed red blood cells, independent of pro-coagulatory management. In alignment with the ESAIC guidelines, the measurement of FXIII in critically ill patients with the risk of bleeding and early management, with the substitution of FXIII at levels <50%-60%, could be suggested.